Down-Regulation of Tumor-Specific Antigens.
As cancer cells progress toward an increasingly malignant state, some of them undergo antigenic modulation as part of this process. This modulation may involve loss of tumor-specific antigens, thereby decreasing the likelihood of an immune response. Another type of modulation is to continually change the nature of the tumor-specific antigens, requiring a corresponding change in immune surveillance before recognition and elimination can occur.